TransMedics Group, Inc. - Common Stock (TMDX)
74.57
+2.43 (3.37%)
Transmedics Group Inc is a biotechnology company focused on revolutionizing the organ transplant process through innovative medical technologies
They have developed a unique organ preservation and transportation system that optimizes the viability of donor organs, specifically targeting hearts, lungs, and livers. By employing advanced perfusion technology, Transmedics aims to improve patient outcomes and increase the availability of transplantable organs, ultimately addressing the critical shortages faced in the transplant community. Their commitment to enhancing the transplant experience positions them as a leader in the field of organ transplantation.
Lowey Dannenberg, P.C. is Investigating TransMedics Group, Inc. (NASDAQ:TMDX) for Potential Violations of the Federal Securities Laws
NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NASDAQTMDX) for potential violations of the federal securities laws.
By Lowey Dannenberg, P.C. · Via GlobeNewswire · February 4, 2025
Bragar Eagel & Squire, P.C. Is Investigating Dave, TransMedics, and Red Cat and Encourages Investors to Contact the Firm
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Dave, Inc. (NASDAQDAVE), TransMedics Group, Inc. NASDAQ:TMDXNASDAQTMDX)(NASDAQ: RCATNASDAQRCAT. Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · February 3, 2025
Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Quanterix Corporation (NASDAQQTRX) and TransMedics Group, Inc. NASDAQ:TMDXNASDAQTMDX)
By Bragar Eagel & Squire · Via GlobeNewswire · January 28, 2025
TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. (NASDAQ: TMDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 18, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 18, 2025
TRANSMEDICS ALERT: Bragar Eagel & Squire, P.C. is Investigating TransMedics Group, Inc. on Behalf of TransMedics Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX) on behalf of TransMedics stockholders. Our investigation concerns whether TransMedics has violated the federal securities laws and/or engaged in other unlawful business practices.
By Bragar Eagel & Squire · Via GlobeNewswire · January 15, 2025
NASDAQ: TMDX Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of TransMedics Group, Inc. (NASDAQTMDX) (“TransMedics”).
By Kessler Topaz Meltzer & Check, LLP · Via Business Wire · January 15, 2025
TMDX Investigation: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors With Significant Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 15, 2025
TMDX Investigation: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors With Significant Losses to Contact the Firm
RADNOR, PA - January 15, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of TransMedics Group, Inc. (NASDAQTMDX) (“TransMedics”).
Via TheNewswire.com · January 15, 2025
TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. (NASDAQ: TMDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 15, 2025
TMDX ALERT: Kaplan Fox & Kilsheimer LLP is Investigating TransMedics Group, Inc. (TMDX) for Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 15, 2025
TMDX ALERT: Kaplan Fox & Kilsheimer LLP is Investigating TransMedics Group, Inc. (TMDX) for Potential Securities Law Violations
NEW YORK - January 15, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
Via TheNewswire.com · January 15, 2025
TMDX Investors Have Opportunity to Join TransMedics Group, Inc. Securities Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. (“TransMedics” or “the Company”) (NASDAQTMDX) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · January 14, 2025
TRANSMEDICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 14, 2025
TRANSMEDICS Investors Are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations
NEW YORK - January 14, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
Via TheNewswire.com · January 14, 2025
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQTMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public.
By Rosen Law Firm · Via Business Wire · January 13, 2025
TRANSMEDICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 13, 2025
TRANSMEDICS Is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
NEW YORK - January 13, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
Via TheNewswire.com · January 13, 2025
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations against TransMedics Group, Inc. (TMDX)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 11, 2025
Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations against TransMedics Group, Inc. (TMDX)
NEW YORK - January 11, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
Via TheNewswire.com · January 11, 2025
Kaplan Fox & Kilsheimer LLP is Investigating TransMedics Group, Inc. (TMDX) for Potential Securities Law Violations
NEW YORK - January 10, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
Via TheNewswire.com · January 10, 2025
Kaplan Fox & Kilsheimer LLP is Investigating TransMedics Group, Inc. (TMDX) for Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · January 10, 2025
Berman Tabacco Announces Investigation of TransMedics Group, Inc. (TMDX) Concerning Claims by Scorpion Capital
BOSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco announces that it is investigating potential securities law violations by TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX).
By Berman Tabacco · Via GlobeNewswire · January 10, 2025
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether TransMedics Group, Inc. (“TransMedics Group” or the “Company”) (NASDAQTMDX) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws.
By Scott+Scott Attorneys at Law LLP · Via Business Wire · November 7, 2024
TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving TransMedics Group, Inc. (NASDAQTMDX) focused on whether the company and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · October 30, 2024
INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm
SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that it is investigating whether TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX) complied with federal securities laws. The Firm’s investigation focuses on whether the Company violated the federal securities laws, issued false and/or misleading statements, and/or failed to disclose information required to be disclosed to investors.
By DiCello Levitt LLP · Via GlobeNewswire · October 28, 2024